Teva launches generic Jadenu tablets

David Salazar
Managing Editor
David Salazar profile picture

Teva Pharmaceuticals is introducing its generic Jadenu (deferasirox) tablets. The generic of Novartis’ branded product will be available in dosage strengths of 90- and 360-mg. 

The drug is an iron chelator indicated to treat chronic iron overload due to blood transfusions in patients 2 years old and older. Teva’s generic comes with a boxed warning for renal failure, hepatic failure and gastrointestinal hemorrhage. 

The product is available in 30-count bottles in both dosage strengths.